Table 4: Comparison of effectiveness between the two arms.

Preemptive ( )Controls ( )

Rates (%) of PUQE ≥ 11 in first 3 weeks of NVP4 (15.4%) ( )9 (39.13%) ( )
AUC of PUQE × Time in 1st trimester (SD)6.38 (1.58) ( )6.11 (2.24) ( )NS
NVP resolved before labor18/23 (78.2%)11/22 (50%)<0.002
Gest. age when NVP resolved (median wk)26330.18
Distribution of HG in previous versus this pregnancy*
 HG in previous pregnancy19110.047*
 HG in present pregnancy66
Mean daily dose of Diclectin {mg/kg (SD)}0.65 (0.23)0.56 (0.24)0.2
Mean gestational age (in weeks)
when NVP symptoms began (SD)
5.30 (1.02)5.45 (1.88)
Mean start of preemptive therapy (SD)3.8 (0.98)

AUC = Area under the curve.